MeSH tree: C16.320
UCLA Health researchers have identified a potential drug target for treating Fragile X syndrome, the most common genetic cause of intellectual disability and autism that affects roughly one in 2,000 boys.
May 18, 2026
0
6
Alpha1-antitrypsin deficiency, an inherited disorder affecting 100,000 people in the U.S., causes a progressive and incurable lung disease. A subset of patients with the condition—about 10% to 15%—also develop liver disease ...
May 17, 2026
0
11
Scientists' discovery of a molecular "switch" that activates an energy-burning pathway in mice has the potential to lead to new treatments for bone disease. The study, published in Nature, sheds new light on brown fat. Unlike ...
May 16, 2026
0
10
When Mayo Clinic researchers sequenced the genomes of 484 seemingly healthy adults, they found that about 13% carried a serious, previously unrecognized genetic risk—conditions those patients did not know about and that standard ...
May 14, 2026
0
3
Friendly skin bacteria could hold the key to stopping eczema in its tracks, according to a breakthrough by a team of UK and Japanese scientists. Their new study reveals harmless microbes living on our skin release powerful ...
May 14, 2026
0
16
Increasing bone density in patients with a rare genetic condition that causes bones to break easily does not prevent fractures, a large clinical trial has found. Patients with brittle bone disease who were given treatments ...
May 14, 2026
0
4
A young zebra finch learning to sing may not sound like much at first, just a babbling stream of chirps and whistles. But scientists at Duke University School of Medicine say that behind the seemingly random chatter is a ...
May 13, 2026
0
8
A study, led by experts at the University of Nottingham, has found that persistent and distressing upper gut symptoms experienced by people with hypermobile Ehlers-Danlos syndrome (hEDS), are not due to structural problems ...
May 13, 2026
0
6
Researchers have uncovered a fundamental rule that governs how genes are physically arranged inside the cell nucleus, and how disruptions to that organization can contribute to human disease.
May 12, 2026
0
6
Rare neuromuscular diseases often lack treatments because developing targeted drugs is slow, costly and risky for companies. A new approach using AI and stem cell models could finally shift the balance.
May 12, 2026
0
4
